Detalhe da pesquisa
1.
Patients With High Cardiovascular Risk as Candidates to Bempedoic Acid, After Treatment With Statins, Ezetimibe and PCSK9 Inhibitors: An Estimation and Cost-Effectiveness Analysis.
J Cardiovasc Pharmacol
; 81(1): 70-75, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219195